***Registration Closed due to Capacity***

"Schizophrenia Update with Emphasis on New Agents"

Speakers

Jonathan Lacro, Pharm.D., BCPS, BCPP (bio)
Location

Napa Valley Grille
502 Horton Plaza (Atop Horton Plaza), San Diego, CA 92101 *  619.238.5440  (Parking Validated)

Mapnapa_valley_grille.gif (24204 bytes)
Date Thursday, September 27th, 2001
6:30-7:00PM - Registration & Dinner
7:00-8:30PM - Program
8:30-8:45PM - Questions & Answers, Certificates
Goals & Objectives

At the end of this presentation, the participant should be able to:

  1. To understand the epidemiology and economic issues surrounding the treatment of schizophrenia.

  2. To discuss the morbidity and mortality rates associated with schizophrenia.

  3. To compare and contrast the characteristics of the conventional and atypical antipsychotic agents.

  4. To understand the receptor profiles of the atypical antipsychotic agents.

  5. To discuss treatment related issues for the atypical antipsychotics including QTc prolongation, weight gain, and serum prolactin levels.

 
Registration Information

Pre-Registration:  Closed due to Capacity

  • FREE - members of SDCPhA & SDSHP
  • $10.00 - non-members

On Site Registration:  None

 Closed due to Capacity

First Name *
Last Name*
 Title*
Work
Position
Work Phone
Home Phone
FAX
E-mail*
Affiliation*
Message

* Required

An ACPE and/or AES certificate for 1.0 hour of accredited continuing education will be awarded the evening of the program for pharmacists completing the program.  (ACPE Program #310-000-01-032-L01)
For more info:  John Johnson, PharmD - SDCPhA/SDSHP CE Coordinator, VM.  760-875-7709, email:  education@sdcpha.com, PO Box 83834, San Diego, CA 92138, FAX  760-875-7709
Program Supported by Pfizer Pharmaceuticals